Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/1999
10/14/1999DE19814084A1 D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung D2 agonist-containing transdermal therapeutic system for the treatment of Parkinson's disease and process for its preparation
10/14/1999CA2327811A1 Short peptides for treatment of neurological degenerative diseases
10/14/1999CA2327705A1 Pharmacological mri (phmri)
10/14/1999CA2327652A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999CA2327513A1 N-aryloxyethyl-indoly-alkylamines for the treatment of depression
10/14/1999CA2327360A1 Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists)
10/14/1999CA2327359A1 N-aryloxyethyl-indoly-alkylamines for the treatment of depression (5-ht1a receptor active agents)
10/14/1999CA2327303A1 N-aryloxyethylamine derivatives for the treatment of depression
10/14/1999CA2327095A1 Compositions containing a combination of a creatine compound and a second agent
10/14/1999CA2327068A1 Maximizing effectiveness of substances used to improve health and well being
10/14/1999CA2326884A1 Thiazolo¬4,5-d|pyrimidines and pyridines as corticotropin releasing factor (crf) antagonists
10/14/1999CA2326606A1 Aminoalkyl substituted 9h-pyridino¬2,3-b|indole and 9h-pyrimidino¬4,5-b|indole derivatives:crf1 and npy1 receptors
10/14/1999CA2326383A1 Aminoalkyl substituted pyrrolo¬2,3-b|pyridine and pyrrolo¬2,3-d|pyrimidine derivatives: modulators of crf1 receptors
10/14/1999CA2326319A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino¬2,3-b|indole and 5,6,7,8-tetrahydro-9h-pyrimidino¬4,5-b|indole derivatives: crf1 specific ligands
10/14/1999CA2326185A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326184A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326146A1 Template associated npy y2-receptor agonists
10/14/1999CA2326140A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2325948A1 Treatment of panic attacks
10/14/1999CA2324984A1 Secreted proteins and polynucleotides encoding them
10/14/1999CA2324976A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof
10/14/1999CA2317572A1 Pharmaceutical compositions and methods for use
10/14/1999CA2317570A1 Pharmaceutical compositions and methods of use
10/14/1999CA2317567A1 Pharmaceutical compositions and methods for use
10/14/1999CA2315946A1 Novel local anesthetic compounds and uses
10/13/1999EP0949332A2 HSSCRG1 polypeptides
10/13/1999EP0949245A1 Process for alkylating hindered sulfonamides
10/13/1999EP0948963A1 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
10/13/1999EP0948622A1 Human mage-like protein
10/13/1999EP0948620A2 Secreted proteins and polynucleotides encoding them
10/13/1999EP0948605A1 Truncated platelet-activating factor acetylhydrolase
10/13/1999EP0948544A1 Monovalent antibody fragments
10/13/1999EP0948534A1 Meningococcus vaccine comprising the valence of bz83 strain
10/13/1999EP0948499A1 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them
10/13/1999EP0948498A1 Sulfonamide compounds having 5-ht receptor activity
10/13/1999EP0948496A2 Substituted pyrimidinone and pyridone compounds and methods of use
10/13/1999EP0948495A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
10/13/1999EP0948493A1 Indene inhibitors of cox-2
10/13/1999EP0948478A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO 1,2-g]-CHROM-3-ENE, BENZO 1,2-g]-THIOCHROM-3-ENE AND BENZO 1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
10/13/1999EP0948330A1 Il-8 receptor antagonists
10/13/1999EP0948325A2 Lamotrigine in the treatment and prophylaxis of migraine
10/13/1999EP0793502A4 Novel hedgehog-derived polypeptides
10/13/1999EP0783486B1 Novel prostaglandin synthase inhibitors
10/13/1999EP0740654B1 Monoamine oxidase b inhibitors, processes for their preparation and use thereof
10/13/1999EP0646116B1 Process and intermediates for bis-aza-bicyclic anxiolytic agents
10/13/1999EP0627915B1 Sprayable analgesic composition and method of use
10/13/1999EP0618968B1 Tools for the diagnosis and treatment of alzheimer's disease
10/13/1999CN1231700A Loxoprofen-containing preparation for external use
10/13/1999CN1231661A Aralkyl and aralkylidene heterocyclic lactams and imides
10/13/1999CN1231611A Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha'
10/13/1999CN1231608A Use of PKC inhibitors for the manufacture of a medicament for the treatment of HTLV-1 infections
10/13/1999CN1231607A Use of inhibitors of PKG for the manufacture of a medicament for the treatment of central nervous system diseases associated with HIV infection
10/13/1999CN1231603A Dosage form providing a sustained and ascending drug release
10/13/1999CN1231601A Oral delayed immediate release formulation and method of preparation therefor
10/13/1999CN1231287A Benzosulfone derivatives
10/13/1999CN1231199A Traditional Chinese medicine for curing neurasthenia
10/13/1999CN1231185A Medicine for curing psychosis and preparation process thereof
10/13/1999CN1045602C Tetrahydropyrido-indole derivant and medicinal composition and pharmaceutical use thereof
10/13/1999CN1045596C Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
10/13/1999CN1045595C Process for the preparation of the intermediates used in the synthesis of 3-aminopiperidine derivatives
10/13/1999CN1045594C Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
10/12/1999US5965744 Ortho-substituted benzoylguanidines, including composition and methods of using them
10/12/1999US5965735 Process for preparing flunixin and intermediates thereof
10/12/1999US5965701 Kappa receptor opioid peptides
10/12/1999US5965693 Isolated polynucleotides; diagnosis and treatment of autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disorder, viricides, bactericides, fungicides and anticarcinogenic agents
10/12/1999US5965625 Consists of a xanthine oxidase inhibitor, a phosphate or a compound capable of releasing phosphate on administering to a patient; enzyme inhibitor are selected from a flavanoid, purines, quinazoline, traiazine and pyrazalo(3,4-d)pyrimidine
10/12/1999US5965609 An antitumor agent, antimalaria agent, bactericide treating gram-negative bacteria and active drug treating stroke, traumatic brain injury, chronic neurodegenerative disease, alzheimer's disease or amyotropic lateral schlerosis
10/12/1999US5965606 Retinoid receptors, 2-fluoro-4-(2',2',4',4'-tetramethyl-8'-trifluoromethylchroman-6' -yl)carbamoyl benzoic acid for treating monocytic leukemia
10/12/1999US5965591 Monoamine oxidase inhibitor; for prophylaxis and treating parkinson's disease, depression and alzheimer's disease
10/12/1999US5965580 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
10/12/1999US5965579 Antagonists of the neurotensin receptors; increasing affinity for human neurotensin receptors
10/12/1999US5965575 N-aryl piperidine compounds as 5HT1B antagonists
10/12/1999US5965571 Cholinesterase inhibitors for treatment of Parkinson's disease
10/12/1999US5965569 Polycyclic aminopyridine compounds which are acetylcholinesterase inhibitors, process for preparing them and their use
10/12/1999US5965564 Enantiomerically pure hydroxylated xanthine compounds
10/12/1999US5965563 Aryl and heteroaryl purine compounds
10/12/1999US5965562 Treating disorders induced by substance p and migraine headache
10/12/1999US5965555 Xanthine compounds having terminally animated alkynol side chains
10/12/1999US5965554 Antipsychotic agents, compositions and method of use
10/12/1999US5965553 Anticholesterol agents, hypotriglyceridemic agents, antiatherosclerosis agents, antifungal agents, alzheimer's agents or anti-acne agents
10/12/1999US5965546 1-[(2-pyrimidinyloxy)alkyl]4-(heteroaryl)piperazines and related compounds and their therapeutic utility
10/12/1999US5965423 A polypeptide; diagnosis of cirrhosis, multiple sclerosis, gastrointestinal disorders, respiratory disorders, acquired immune defiency syndrome; antiarthritic/antiischemic/ antiallergens/ antiproliferactive agents
10/12/1999US5965420 A protein which stimulates cell proliferation; treatment of bone loss due to osteoporosis; treat adult respiratory disease syndrome, parkinson'disease, huntington's disease; antiarthritic/anticarcinogenic agents; antiallergens
10/12/1999US5965413 Process for producing phosphatidylserines having long chain unsaturated fatty acid as side chain
10/12/1999US5965397 Protein factor, cytokines, lymphokines, interferons, and interleukins, and colony stimulating factors; treatment of osteoporosis, stimulating or bone growth, regeneration of nerve and brain tissue, alzheimer/huntington disease's
10/12/1999US5965388 Isolated polynucleotides; diagnosis and treatment autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disease; viricides, bactericides and fungicides; anticarcinogenic agents
10/12/1999US5965367 Purified bradykinin B1 receptor
10/12/1999US5965365 A human growth factor receptor binding gene; treatment and diagnosis of smooth muscle disorders; antiproliferative/ anticarcinogenic/antitumor agents
10/12/1999US5964224 Method for treating amyotrophic lateral sclerosis and a therapeutic agent therefor
10/10/1999CA2273546A1 Nefazodone dosage form
10/07/1999WO1999050393A2 Use of stimulated peripheral blood mononuclear cells for the treatment of brain-related diseases, disorders and damage
10/07/1999WO1999050272A1 Phosphinic acid derivatives
10/07/1999WO1999050268A2 Substituted indolealkanoic acids
10/07/1999WO1999050249A2 Pyrimidines and triazines as integrin antagonists
10/07/1999WO1999050247A1 Compounds with activity on muscarinic receptors
10/07/1999WO1999050225A1 Aminocyclohexyl ether compounds and uses thereof
10/07/1999WO1999049867A1 Novel galenic formulations of meloxicam for oral administration
10/07/1999WO1999049864A1 Indole-2,3-dione-3-oxime derivatives for therapeutic use
10/07/1999WO1999049857A1 Stable dosage forms of fluoxetine and its enantiomers
10/07/1999WO1999049856A2 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
1 ... 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 ... 1833